Skip to main content

Advertisement

SpringerLink
Log in

Towards an optimal treatment strategy for patients with oesophageal cancer

  • Editorial
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pera M, Manterola C, Vidal O et al (2005) Epidemiology of esophageal carcinoma. J Surg Oncol 92:151–159

    Article  PubMed  Google Scholar 

  2. Kleinberg L, Forastiere AA (2007) Chemoradiation in the management of esophageal cancer. J Clin Oncol 25:4110–4117

    Article  PubMed  CAS  Google Scholar 

  3. Diederich S (2007) Staging of oesophageal cancer. Cancer Imaging 7:S63–S66

    Article  PubMed  Google Scholar 

  4. Theisen J, Feith M, Stein HJ, Siewert JR (2007) Management of early esophageal cancer. Adv Surg 41:229–239

    Article  PubMed  CAS  Google Scholar 

  5. Graham AJ, Shrive FM, Ghali WA et al (2007) Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 83:1257–1264

    Article  PubMed  Google Scholar 

  6. Fok M, Sham JS, Choy D et al (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147

    PubMed  CAS  Google Scholar 

  7. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733

    Article  Google Scholar 

  8. Fok M, McShane J, Law SYK et al (1994) Prospective randomised study on radiotherapy and surgery in the treatment of oesophageal carcinoma. Asian J Surg 17:223–229

    Google Scholar 

  9. Bhansali M, Vaidya J, Bhatt R et al (1996) Chemotherapy for carcinoma of the oesophagus: a comparison of evidence from meta-analyses of randomised trials and of historical control studies. Ann Oncol 7:355–359

    PubMed  CAS  Google Scholar 

  10. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  11. Arnott SJ, Duncan W, Gignoux M et al (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 4:CD001799

    Google Scholar 

  12. Gebski V, Burnmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    Article  PubMed  CAS  Google Scholar 

  13. Greil R, Stein H (2007) Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer? Lancet Oncol 8:189–190

    Article  PubMed  Google Scholar 

  14. Sartor CI (2004) Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors. Bat Clin Pract Oncol 1:80–87

    Article  CAS  Google Scholar 

  15. Luthra R, Wu TT, Luthra MG et al (2006) Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24:259–267

    Article  PubMed  CAS  Google Scholar 

  16. Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21:4604–4610

    Article  PubMed  CAS  Google Scholar 

  17. Sugahara S, Tokuuye K, Okumura T et al (2005) Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 61:76–84

    PubMed  Google Scholar 

  18. Konski A, Doss M, Milestone B et al (2005) The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123–1128

    PubMed  Google Scholar 

  19. Minsky BD, Pajak T, Ginsberg RJ et al (2002) INT 0123 (RTOG 94-05) phase III trial of combined modality therapy for esophageal cancer: high dose (64.8 Gy) vs. standard dose (50.4 Gy) radiation therapy. J Clin Oncol 20:1167–1174

    Article  PubMed  CAS  Google Scholar 

  20. Crehange G, Maingon P, Peignaux K et al (2007) Phase III trial of protracted compared with split-course chemordiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. J Clin Oncol 25:4895–4901

    Article  PubMed  CAS  Google Scholar 

  21. Herskovic A, Martz LK, Al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Eng J Med 326:1593–1598

    CAS  Google Scholar 

  22. Bedenne L, Michel P, Bouche O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168

    Article  PubMed  CAS  Google Scholar 

  23. Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Oncología Médica, Hospital General Universitario de Elche, C/ Camí de l’Almazara, 11, ES-03203, Elche, Alicante, Spain

    Javier Gallego Plazas & Vanesa Pons Sanz

Authors
  1. Javier Gallego Plazas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanesa Pons Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier Gallego Plazas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plazas, J.G., Sanz, V.P. Towards an optimal treatment strategy for patients with oesophageal cancer. Clin Transl Oncol 10, 131–133 (2008). https://doi.org/10.1007/s12094-008-0168-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-008-0168-y

Search

Navigation